{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T12:03:05Z","timestamp":1794744185026,"version":"4.9.1"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,6,29]],"date-time":"2018-06-29T00:00:00Z","timestamp":1530230400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000265","name":"UK Medical Research Council","doi-asserted-by":"crossref","award":["G0400074"],"award-info":[{"award-number":["G0400074"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Austrian Research Promotion Agency FFG","award":["844453, 851079, 855287"],"award-info":[{"award-number":["844453, 851079, 855287"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["acta neuropathol commun"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s40478-018-0557-6","type":"journal-article","created":{"date-parts":[[2018,6,29]],"date-time":"2018-06-29T03:51:02Z","timestamp":1530244262000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":360,"title":["Phosphorylation of different tau sites during progression of Alzheimer\u2019s disease"],"prefix":"10.1186","volume":"6","author":[{"given":"Joerg","family":"Neddens","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena","family":"Temmel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefanie","family":"Flunkert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bianca","family":"Kerschbaumer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Hoeller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tina","family":"Loeffler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vera","family":"Niederkofler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guenther","family":"Daum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Attems","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3699-2227","authenticated-orcid":false,"given":"Birgit","family":"Hutter-Paier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,6,29]]},"reference":[{"key":"557_CR1","doi-asserted-by":"crossref","unstructured":"Alafuzoff I, Arzberger T, Al-Sarraj S, Bodi I, Bogdanovic N, Braak H, Bugiani O, Del-Tredici K, Ferrer I, Gelpi E et al (2008) Staging of neurofibrillary pathology in Alzheimer's disease: a study of the BrainNet Europe consortium. Brain Pathol 18: 484\u2013496 doi 10.1111\/j.1750-3639.2008.00147.x","DOI":"10.1111\/j.1750-3639.2008.00147.x"},{"issue":"833","key":"557_CR2","doi-asserted-by":"publisher","first-page":"e831","DOI":"10.1016\/j.neurobiolaging.2011.08.001","volume":"33","author":"G Amadoro","year":"2012","unstructured":"Amadoro G, Corsetti V, Atlante A, Florenzano F, Capsoni S, Bussani R, Mercanti D, Calissano P (2012) Interaction between NH(2)-tau fragment and Abeta in Alzheimer's disease mitochondria contributes to the synaptic deterioration. Neurobiol Aging 33(833):e831\u2013e825. \n                    https:\/\/doi.org\/10.1016\/j.neurobiolaging.2011.08.001","journal-title":"Neurobiol Aging"},{"key":"557_CR3","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1016\/j.neurobiolaging.2009.06.005","volume":"32","author":"G Amadoro","year":"2011","unstructured":"Amadoro G, Corsetti V, Ciotti MT, Florenzano F, Capsoni S, Amato G, Calissano P (2011) Endogenous Abeta causes cell death via early tau hyperphosphorylation. Neurobiol Aging 32:969\u2013990. \n                    https:\/\/doi.org\/10.1016\/j.neurobiolaging.2009.06.005","journal-title":"Neurobiol Aging"},{"key":"557_CR4","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1046\/j.1471-4159.2003.01879.x","volume":"86","author":"C Andorfer","year":"2003","unstructured":"Andorfer C, Kress Y, Espinoza M, de Silva R, Tucker KL, Barde YA, Duff K, Davies P (2003) Hyperphosphorylation and aggregation of tau in mice expressing normal human tau isoforms. J Neurochem 86:582\u2013590","journal-title":"J Neurochem"},{"key":"557_CR5","doi-asserted-by":"publisher","first-page":"4365","DOI":"10.1021\/jm5017544","volume":"58","author":"M Ariza","year":"2015","unstructured":"Ariza M, Kolb HC, Moechars D, Rombouts F, Andres JI (2015) Tau positron emission tomography (PET) imaging: past, present, and future. J Med Chem 58:4365\u20134382. \n                    https:\/\/doi.org\/10.1021\/jm5017544","journal-title":"J Med Chem"},{"issue":"Pt 3","key":"557_CR6","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1042\/bj3230577","volume":"323","author":"ML Billingsley","year":"1997","unstructured":"Billingsley ML, Kincaid RL (1997) Regulated phosphorylation and dephosphorylation of tau protein: effects on microtubule interaction, intracellular trafficking and neurodegeneration. Biochem J 323(Pt 3):577\u2013591","journal-title":"Biochem J"},{"key":"557_CR7","doi-asserted-by":"publisher","first-page":"3514","DOI":"10.1523\/JNEUROSCI.5425-05.2006","volume":"26","author":"K Boekhoorn","year":"2006","unstructured":"Boekhoorn K, Terwel D, Biemans B, Borghgraef P, Wiegert O, Ramakers GJ, de Vos K, Krugers H, Tomiyama T, Mori H et al (2006) Improved long-term potentiation and memory in young tau-P301L transgenic mice before onset of hyperphosphorylation and tauopathy. J Neurosci 26:3514\u20133523. \n                    https:\/\/doi.org\/10.1523\/JNEUROSCI.5425-05.2006","journal-title":"J Neurosci"},{"key":"557_CR8","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/s00401-006-0127-z","volume":"112","author":"H Braak","year":"2006","unstructured":"Braak H, Alafuzoff I, Arzberger T, Kretzschmar H, Del Tredici K (2006) Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry. Acta Neuropathol 112:389\u2013404. \n                    https:\/\/doi.org\/10.1007\/s00401-006-0127-z","journal-title":"Acta Neuropathol"},{"key":"557_CR9","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/BF00308809","volume":"82","author":"H Braak","year":"1991","unstructured":"Braak H, Braak E (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 82:239\u2013259","journal-title":"Acta Neuropathol"},{"key":"557_CR10","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1016\/0896-6273(93)90057-X","volume":"10","author":"GT Bramblett","year":"1993","unstructured":"Bramblett GT, Goedert M, Jakes R, Merrick SE, Trojanowski JQ, Lee VM (1993) Abnormal tau phosphorylation at Ser396 in Alzheimer's disease recapitulates development and contributes to reduced microtubule binding. Neuron 10:1089\u20131099","journal-title":"Neuron"},{"key":"557_CR11","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1111\/j.1471-4159.2010.06687.x","volume":"113","author":"KH Chang","year":"2010","unstructured":"Chang KH, de Pablo Y, Lee HP, Lee HG, Smith MA, Shah K (2010) Cdk5 is a major regulator of p38 cascade: relevance to neurotoxicity in Alzheimer's disease. J Neurochem 113:1221\u20131229. \n                    https:\/\/doi.org\/10.1111\/j.1471-4159.2010.06687.x","journal-title":"J Neurochem"},{"key":"557_CR12","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1111\/j.1471-4159.2004.02155.x","volume":"88","author":"JH Cho","year":"2004","unstructured":"Cho JH, Johnson GV (2004) Primed phosphorylation of tau at Thr231 by glycogen synthase kinase 3beta (GSK3beta) plays a critical role in regulating tau's ability to bind and stabilize microtubules. J Neurochem 88:349\u2013358","journal-title":"J Neurochem"},{"key":"557_CR13","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/alzrt259","volume":"6","author":"C Cook","year":"2014","unstructured":"Cook C, Stankowski JN, Carlomagno Y, Stetler C, Petrucelli L (2014) Acetylation: a new key to unlock tau's role in neurodegeneration. Alzheimers Res Ther 6:29. \n                    https:\/\/doi.org\/10.1186\/alzrt259","journal-title":"Alzheimers Res Ther"},{"key":"557_CR14","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1159\/000338152","volume":"11","author":"S Flunkert","year":"2013","unstructured":"Flunkert S, Hierzer M, Loffler T, Rabl R, Neddens J, Duller S, Schofield EL, Ward MA, Posch M, Jungwirth H et al (2013) Elevated levels of soluble total and hyperphosphorylated tau result in early behavioral deficits and distinct changes in Brain Pathol in a new tau transgenic mouse model. Neurodegener Dis 11:194\u2013205. \n                    https:\/\/doi.org\/10.1159\/000338152","journal-title":"Neurodegener Dis"},{"key":"557_CR15","doi-asserted-by":"publisher","first-page":"5066","DOI":"10.1073\/pnas.90.11.5066","volume":"90","author":"M Goedert","year":"1993","unstructured":"Goedert M, Jakes R, Crowther RA, Six J, Lubke U, Vandermeeren M, Cras P, Trojanowski JQ, Lee VM (1993) The abnormal phosphorylation of tau protein at Ser-202 in Alzheimer disease recapitulates phosphorylation during development. Proc Natl Acad Sci U S A 90:5066\u20135070","journal-title":"Proc Natl Acad Sci U S A"},{"key":"557_CR16","doi-asserted-by":"publisher","first-page":"11500","DOI":"10.1523\/JNEUROSCI.3203-08.2008","volume":"28","author":"KN Green","year":"2008","unstructured":"Green KN, Steffan JS, Martinez-Coria H, Sun X, Schreiber SS, Thompson LM, LaFerla FM (2008) Nicotinamide restores cognition in Alzheimer's disease transgenic mice via a mechanism involving sirtuin inhibition and selective reduction of Thr231-phosphotau. J Neurosci 28:11500\u201311510. \n                    https:\/\/doi.org\/10.1523\/JNEUROSCI.3203-08.2008","journal-title":"J Neurosci"},{"key":"557_CR17","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.2967\/jnumed.114.139550","volume":"55","author":"H Hashimoto","year":"2014","unstructured":"Hashimoto H, Kawamura K, Igarashi N, Takei M, Fujishiro T, Aihara Y, Shiomi S, Muto M, Ito T, Furutsuka K et al (2014) Radiosynthesis, photoisomerization, biodistribution, and metabolite analysis of 11C-PBB3 as a clinically useful PET probe for imaging of tau pathology. J Nucl Med 55:1532\u20131538. \n                    https:\/\/doi.org\/10.2967\/jnumed.114.139550","journal-title":"J Nucl Med"},{"key":"557_CR18","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.cell.2010.06.036","volume":"142","author":"LM Ittner","year":"2010","unstructured":"Ittner LM, Ke YD, Delerue F, Bi M, Gladbach A, van Eersel J, Wolfing H, Chieng BC, Christie MJ, Napier IA et al (2010) Dendritic function of tau mediates amyloid-beta toxicity in Alzheimer's disease mouse models. Cell 142:387\u2013397. \n                    https:\/\/doi.org\/10.1016\/j.cell.2010.06.036","journal-title":"Cell"},{"key":"557_CR19","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.2967\/jnumed.110.077164","volume":"51","author":"A Kadir","year":"2010","unstructured":"Kadir A, Nordberg A (2010) Target-specific PET probes for neurodegenerative disorders related to dementia. J Nucl Med 51:1418\u20131430. \n                    https:\/\/doi.org\/10.2967\/jnumed.110.077164","journal-title":"J Nucl Med"},{"key":"557_CR20","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1007\/s00401-016-1632-3","volume":"132","author":"DJ Koss","year":"2016","unstructured":"Koss DJ, Jones G, Cranston A, Gardner H, Kanaan NM, Platt B (2016) Soluble pre-fibrillar tau and beta-amyloid species emerge in early human Alzheimer's disease and track disease progression and cognitive decline. Acta Neuropathol 132:875\u2013895. \n                    https:\/\/doi.org\/10.1007\/s00401-016-1632-3","journal-title":"Acta Neuropathol"},{"key":"557_CR21","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/S0197-4580(02)00228-2","volume":"24","author":"J Lauckner","year":"2003","unstructured":"Lauckner J, Frey P, Geula C (2003) Comparative distribution of tau phosphorylated at Ser262 in pre-tangles and tangles. Neurobiol Aging 24:767\u2013776","journal-title":"Neurobiol Aging"},{"key":"557_CR22","doi-asserted-by":"publisher","first-page":"2304","DOI":"10.1523\/JNEUROSCI.4162-03.2004","volume":"24","author":"G Lee","year":"2004","unstructured":"Lee G, Thangavel R, Sharma VM, Litersky JM, Bhaskar K, Fang SM, Do LH, Andreadis A, Van Hoesen G, Ksiezak-Reding H (2004) Phosphorylation of tau by fyn: implications for Alzheimer's disease. J Neurosci 24:2304\u20132312. \n                    https:\/\/doi.org\/10.1523\/JNEUROSCI.4162-03.2004","journal-title":"J Neurosci"},{"key":"557_CR23","doi-asserted-by":"publisher","first-page":"3134","DOI":"10.1021\/bi051635j","volume":"45","author":"T Li","year":"2006","unstructured":"Li T, Hawkes C, Qureshi HY, Kar S, Paudel HK (2006) Cyclin-dependent protein kinase 5 primes microtubule-associated protein tau site-specifically for glycogen synthase kinase 3beta. Biochemistry 45:3134\u20133145. \n                    https:\/\/doi.org\/10.1021\/bi051635j","journal-title":"Biochemistry"},{"key":"557_CR24","doi-asserted-by":"publisher","first-page":"3125","DOI":"10.1021\/bi051634r","volume":"45","author":"T Li","year":"2006","unstructured":"Li T, Paudel HK (2006) Glycogen synthase kinase 3beta phosphorylates Alzheimer's disease-specific Ser396 of microtubule-associated protein tau by a sequential mechanism. Biochemistry 45:3125\u20133133. \n                    https:\/\/doi.org\/10.1021\/bi051634r","journal-title":"Biochemistry"},{"key":"557_CR25","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1007\/BF03182770","volume":"47","author":"X Liao","year":"2004","unstructured":"Liao X, Zhang Y, Wang Y, Wang J (2004) The effect of cdk-5 overexpression on tau phosphorylation and spatial memory of rat. Sci China Ser C Life Sci 47:251\u2013257","journal-title":"Sci China Ser C Life Sci"},{"key":"557_CR26","doi-asserted-by":"publisher","first-page":"5384","DOI":"10.1073\/pnas.89.12.5384","volume":"89","author":"B Lichtenberg-Kraag","year":"1992","unstructured":"Lichtenberg-Kraag B, Mandelkow EM, Biernat J, Steiner B, Schroter C, Gustke N, Meyer HE, Mandelkow E (1992) Phosphorylation-dependent epitopes of neurofilament antibodies on tau protein and relationship with Alzheimer tau. Proc Natl Acad Sci U S A 89:5384\u20135388","journal-title":"Proc Natl Acad Sci U S A"},{"key":"557_CR27","doi-asserted-by":"publisher","first-page":"29","DOI":"10.3233\/JAD-2005-8104","volume":"8","author":"J Luna-Munoz","year":"2005","unstructured":"Luna-Munoz J, Garcia-Sierra F, Falcon V, Menendez I, Chavez-Macias L, Mena R (2005) Regional conformational change involving phosphorylation of tau protein at the Thr231, precedes the structural change detected by Alz-50 antibody in Alzheimer's disease. J Alzheimer's Dis: JAD 8:29\u201341","journal-title":"J Alzheimer's Dis: JAD"},{"key":"557_CR28","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1111\/bpa.12001","volume":"23","author":"H Lund","year":"2013","unstructured":"Lund H, Cowburn RF, Gustafsson E, Stromberg K, Svensson A, Dahllund L, Malinowsky D, Sunnemark D (2013) Tau-tubulin kinase 1 expression, phosphorylation and co-localization with phospho-Ser422 tau in the Alzheimer's disease Brain. Brain Pathol 23:378\u2013389. \n                    https:\/\/doi.org\/10.1111\/bpa.12001","journal-title":"Brain Pathol"},{"key":"557_CR29","doi-asserted-by":"publisher","first-page":"16586","DOI":"10.1073\/pnas.1417548111","volume":"111","author":"HB Luo","year":"2014","unstructured":"Luo HB, Xia YY, Shu XJ, Liu ZC, Feng Y, Liu XH, Yu G, Yin G, Xiong YS, Zeng K et al (2014) SUMOylation at K340 inhibits tau degradation through deregulating its phosphorylation and ubiquitination. Proc Natl Acad Sci U S A 111:16586\u201316591. \n                    https:\/\/doi.org\/10.1073\/pnas.1417548111","journal-title":"Proc Natl Acad Sci U S A"},{"key":"557_CR30","doi-asserted-by":"publisher","first-page":"940603","DOI":"10.1155\/2013\/940603","volume":"2013","author":"S Mondragon-Rodriguez","year":"2013","unstructured":"Mondragon-Rodriguez S, Perry G, Zhu X, Moreira PI, Acevedo-Aquino MC, Williams S (2013) Phosphorylation of tau protein as the link between oxidative stress, mitochondrial dysfunction, and connectivity failure: implications for Alzheimer's disease. Oxidative Med Cell Longev 2013:940603. \n                    https:\/\/doi.org\/10.1155\/2013\/940603","journal-title":"Oxidative Med Cell Longev"},{"key":"557_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00401-011-0910-3","volume":"123","author":"TJ Montine","year":"2012","unstructured":"Montine TJ, Phelps CH, Beach TG, Bigio EH, Cairns NJ, Dickson DW, Duyckaerts C, Frosch MP, Masliah E, Mirra SS et al (2012) National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease: a practical approach. Acta Neuropathologica 123:1\u201311. \n                    https:\/\/doi.org\/10.1007\/s00401-011-0910-3","journal-title":"Acta Neuropathologica"},{"key":"557_CR32","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.1016\/j.neurobiolaging.2014.12.001","volume":"36","author":"AJ Moszczynski","year":"2015","unstructured":"Moszczynski AJ, Gohar M, Volkening K, Leystra-Lantz C, Strong W, Strong MJ (2015) Thr175-phosphorylated tau induces pathologic fibril formation via GSK3beta-mediated phosphorylation of Thr231 in vitro. Neurobiol Aging 36:1590\u20131599. \n                    https:\/\/doi.org\/10.1016\/j.neurobiolaging.2014.12.001","journal-title":"Neurobiol Aging"},{"key":"557_CR33","doi-asserted-by":"publisher","first-page":"133","DOI":"10.3389\/fendo.2018.00133","volume":"9","author":"D Munoz-Mayorga","year":"2018","unstructured":"Munoz-Mayorga D, Guerra-Araiza C, Torner L, Morales T (2018) Tau phosphorylation in female neurodegeneration: role of estrogens, progesterone, and prolactin. Front Endocrinol 9:133. \n                    https:\/\/doi.org\/10.3389\/fendo.2018.00133","journal-title":"Front Endocrinol"},{"key":"557_CR34","first-page":"346","volume":"107","author":"M Pevalova","year":"2006","unstructured":"Pevalova M, Filipcik P, Novak M, Avila J, Iqbal K (2006) Post-translational modifications of tau protein. Bratislavske Lekarske Listy 107:346\u2013353","journal-title":"Bratislavske Lekarske Listy"},{"key":"557_CR35","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1523\/JNEUROSCI.4152-10.2011","volume":"31","author":"ED Roberson","year":"2011","unstructured":"Roberson ED, Halabisky B, Yoo JW, Yao J, Chin J, Yan F, Wu T, Hamto P, Devidze N, Yu GQ et al (2011) Amyloid-beta\/Fyn-induced synaptic, network, and cognitive impairments depend on tau levels in multiple mouse models of Alzheimer's disease. J Neurosci 31:700\u2013711. \n                    https:\/\/doi.org\/10.1523\/JNEUROSCI.4152-10.2011","journal-title":"J Neurosci"},{"key":"557_CR36","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.mcna.2012.12.017","volume":"97","author":"CC Rowe","year":"2013","unstructured":"Rowe CC, Villemagne VL (2013) Amyloid imaging with PET in early Alzheimer disease diagnosis. Med Clin North Am 97:377\u2013398. \n                    https:\/\/doi.org\/10.1016\/j.mcna.2012.12.017","journal-title":"Med Clin North Am"},{"key":"557_CR37","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/1750-1326-6-12","volume":"6","author":"TM Scales","year":"2011","unstructured":"Scales TM, Derkinderen P, Leung KY, Byers HL, Ward MA, Price C, Bird IN, Perera T, Kellie S, Williamson R et al (2011) Tyrosine phosphorylation of tau by the SRC family kinases lck and fyn. Mol Neurodegen 6:12. \n                    https:\/\/doi.org\/10.1186\/1750-1326-6-12","journal-title":"Mol Neurodegen"},{"key":"557_CR38","doi-asserted-by":"publisher","unstructured":"Simic G, Babic Leko M, Wray S, Harrington C, Delalle I, Jovanov-Milosevic N, Bazadona D, Buee L, de Silva R, Di Giovanni G et al (2016) Tau protein hyperphosphorylation and aggregation in Alzheimer's disease and other Tauopathies, and possible neuroprotective strategies. Biomolecules 6: 6 doi \n                    https:\/\/doi.org\/10.3390\/biom6010006","DOI":"10.3390\/biom6010006"},{"key":"557_CR39","doi-asserted-by":"publisher","first-page":"2358","DOI":"10.1097\/00001756-199411000-00037","volume":"5","author":"JH Su","year":"1994","unstructured":"Su JH, Cummings BJ, Cotman CW (1994) Early phosphorylation of tau in Alzheimer's disease occurs at Ser-202 and is preferentially located within neurites. Neuroreport 5:2358\u20132362","journal-title":"Neuroreport"},{"key":"557_CR40","doi-asserted-by":"publisher","first-page":"42","DOI":"10.3389\/fnmol.2014.00042","volume":"7","author":"S Tenreiro","year":"2014","unstructured":"Tenreiro S, Eckermann K, Outeiro TF (2014) Protein phosphorylation in neurodegeneration: friend or foe? Front Mol Neurosci 7:42. \n                    https:\/\/doi.org\/10.3389\/fnmol.2014.00042","journal-title":"Front Mol Neurosci"},{"key":"557_CR41","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1212\/WNL.58.12.1791","volume":"58","author":"DR Thal","year":"2002","unstructured":"Thal DR, Rub U, Orantes M, Braak H (2002) Phases of a beta-deposition in the human brain and its relevance for the development of AD. Neurology 58:1791\u20131800","journal-title":"Neurology"},{"key":"557_CR42","doi-asserted-by":"publisher","first-page":"2927","DOI":"10.1111\/j.1742-4658.2011.08218.x","volume":"278","author":"A Usardi","year":"2011","unstructured":"Usardi A, Pooler AM, Seereeram A, Reynolds CH, Derkinderen P, Anderton B, Hanger DP, Noble W, Williamson R (2011) Tyrosine phosphorylation of tau regulates its interactions with Fyn SH2 domains, but not SH3 domains, altering the cellular localization of tau. FEBS J 278:2927\u20132937. \n                    https:\/\/doi.org\/10.1111\/j.1742-4658.2011.08218.x","journal-title":"FEBS J"},{"key":"557_CR43","doi-asserted-by":"publisher","unstructured":"Walker L, McAleese KE, Johnson M, Khundakar AA, Erskine D, Thomas AJ, McKeith IG, Attems J (2017) Quantitative neuropathology: an update on automated methodologies and implications for large scale cohorts. J Neural Transm (Vienna). \n                    https:\/\/doi.org\/10.1007\/s00702-017-1702-2","DOI":"10.1007\/s00702-017-1702-2"},{"key":"557_CR44","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1523\/JNEUROSCI.22-01-00010.2002","volume":"22","author":"R Williamson","year":"2002","unstructured":"Williamson R, Scales T, Clark BR, Gibb G, Reynolds CH, Kellie S, Bird IN, Varndell IM, Sheppard PW, Everall I et al (2002) Rapid tyrosine phosphorylation of neuronal proteins including tau and focal adhesion kinase in response to amyloid-beta peptide exposure: involvement of Src family protein kinases. J Neurosci 22:10\u201320","journal-title":"J Neurosci"},{"key":"557_CR45","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1096\/fj.07-9766com","volume":"22","author":"R Williamson","year":"2008","unstructured":"Williamson R, Usardi A, Hanger DP, Anderton BH (2008) Membrane-bound beta-amyloid oligomers are recruited into lipid rafts by a fyn-dependent mechanism. FASEB J 22:1552\u20131559. \n                    https:\/\/doi.org\/10.1096\/fj.07-9766com","journal-title":"FASEB J"},{"key":"557_CR46","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/j.nbd.2006.01.006","volume":"22","author":"XW Zhou","year":"2006","unstructured":"Zhou XW, Li X, Bjorkdahl C, Sjogren MJ, Alafuzoff I, Soininen H, Grundke-Iqbal I, Iqbal K, Winblad B, Pei JJ (2006) Assessments of the accumulation severities of amyloid beta-protein and hyperphosphorylated tau in the medial temporal cortex of control and Alzheimer's brains. Neurobiol Dis 22:657\u2013668. \n                    https:\/\/doi.org\/10.1016\/j.nbd.2006.01.006","journal-title":"Neurobiol Dis"}],"container-title":["Acta Neuropathologica Communications"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-018-0557-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s40478-018-0557-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-018-0557-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,28]],"date-time":"2019-06-28T19:05:39Z","timestamp":1561748739000},"score":1,"resource":{"primary":{"URL":"https:\/\/actaneurocomms.biomedcentral.com\/articles\/10.1186\/s40478-018-0557-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,29]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["557"],"URL":"https:\/\/doi.org\/10.1186\/s40478-018-0557-6","relation":{},"ISSN":["2051-5960"],"issn-type":[{"value":"2051-5960","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,29]]},"assertion":[{"value":"24 May 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Human tissue was provided by the Newcastle Brain Tissue Resource (NBTR), Newcastle University, UK in accordance with the approval of the joint Ethics Committee of Newcastle and North Tyneside Health Authority and following NBTR brain banking procedures.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"JN, MT, SF, BK, CH, TL, VN and BHP are employees of QPS Austria GmbH. The authors declare that they have no other competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"52"}}